Cancer treatment: Understanding risks and side effects
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Mar-2026 15:15 ET (31-Mar-2026 19:15 GMT/UTC)
Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilise the disease and alleviate symptoms. One such therapy is to treat the patient with their own stem cells. This often involves weeks in hospital. Using machine learning methods, a research team has now assessed the conditions in which some of the therapy can be safely carried out as an outpatient. The study was conducted by researchers from the Göttingen Campus Institute for Dynamics of Biological Networks (CIDBN) at the University of Göttingen, the University Medical Center Göttingen (UMG), and the University Medical Center Bielefeld (OWL). It was published in the journal npj digital medicine.
A collaborative effort between researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and Shenzhen University School of Medicine has provided the first proof-of-principle study demonstrating that targeting a receptor on the surface of anti-inflammatory regulatory T cells (Tregs) can restore their function and alleviate asthma in mice. The study, published March 17 in Life Science Alliance (LSA), shows that targeting the Dectin-1 receptor reprograms the epigenetic landscape of compromised Tregs and renews their ability to express two core Treg genes. These findings offer a promising novel therapeutic avenue for the treatment of allergic asthma and, potentially, other immune-mediated diseases.
Placing fruit and vegetable sections near supermarket entrances increases the amount purchased and may improve the quality of women’s diets, according to a new study funded by the National Institute for Health and Care Research (NIHR).
New research from Washington University School of Medicine in St. Louis adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of neurodegenerative diseases. In lab experiments, the researchers found that exposure to a novel compound can clear a harmful protein from human neurons modeling frontotemporal dementia — a devastating and ultimately fatal condition — and prevent those neurons from dying.